(The Center Square) - The U.S. Supreme Court on Thursday ruled that women can continue to access abortion drugs through the mail without making an in-person doctor's visit, while a lawsuit continues against the practice. 

Justices on the high court graned two emergency requests from Danco Laboratories and GenProBio, two makers of the abortion drug mifepristone. 

 

Originally published on thecentersquare.com, part of the BLOX Digital Content Exchange.

Locations

Recommended for you